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Abstract
Background: To determine the incidence of later cancer detection and its risk factors after the first diagnostic
ureteroscopy.
Methods: One hundred and sixty-six patients undergoing diagnostic ureteroscopy based on the suspicion of
urothelial carcinoma of the upper urinary tract (UC of the UUT) between 1995 and 2012 were included. We
examined the diagnostic outcome of the initial ureteroscopy. Thereafter, we collected follow-up data on patients
who had not been diagnosed with UC of the UUT at the first examination, and evaluated the incidence of later
cancer detection and its risk factors using Cox hazard models.
Results: Of the 166 patients, 76 (45.8 %) were diagnosed with UC of the UUT at the first diagnostic ureteroscopy.
The remaining 90 (54.2 %) were diagnosed with other malignancies (n = 22), non-malignant disorders (n = 18), or
without disorders (n = 50). Of these 90 patients, follow-up data were available in 65 patients (median: 41 months,
range: 3–170). During the follow-up, carcinoma was detected in 6 patients (6/65, 9.2 %) at a median of 43.5 months
(range: 10–59). Episodes of gross hematuria (p = 0.0048) and abnormal cytological findings (p = 0.0335) during the
follow-up and a male sex (p = 0.0316) were adverse risk factors.
Conclusion: Later cancer detection of UC of the UUT was not uncommon after the first examination. The risk
analysis revealed the aforementioned characteristics.
Background
Based on recent advances in medical equipment, ure-
teroscopy has become a powerful tool for the diagnosis
and endoscopic treatment of patients with urothelial car-
cinoma (UC) of the upper urinary tract (UUT) [1–6].
The combination of direct visual examination and tumor
biopsy by endoscopic cold forceps has led to marked
diagnostic accuracy. However, there are potential limita-
tions, such as the endoscopic view can be easily compro-
mised by bleeding, and tissue samples obtained using
endoscopic forceps are too small to yield a definitive
diagnosis regarding the presence or absence of malig-
nancy. In that situation, subsequent follow-up would be
necessary. Data regarding these issues have not been re-
ported. In the present study, we evaluated diagnostic
outcomes of ureteroscopy and collected follow-up data
on patients who were not considered to have UC of the
UUT at the first examination. The aim of this study was
to clarify the incidence of later cancer detection and its
risk factors after the first examination.
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access patient data, the medical records of patients under-
going ureteroscopy under general or lumbar anesthesia at
Hokkaido University Hospital between 1995 and 2012
were reviewed. During this period, 208 patients underwent
ureteroscopic procedures. For the present analyses, pa-
tients undergoing ureteroscopy mainly for endoscopic
treatment for UC of the UUT, urolithiasis, or other dis-
eases were excluded (n = 16). In addition, because of the
special circumstances, patients undergoing ureteroscopy
through an antegrade approach, an ileal conduit, or ure-
terocutaneostomy were excluded (n = 16). Patients under
18 years old (n = 2), those undergoing ureteroscopy for
the removal of a migrated stent (n = 3), those with failure
on ureteroscopy (n = 4), and a patient undergoing uretero-
scopy for suspicion of recurrence after conservative
treatment of UC of the UUT at the previous hospital were
also excluded. Finally, 166 patients undergoing diagnostic
ureteroscopy to obtain a diagnosis of UC of the UUT were
included. Regarding the indication of diagnostic uretero-
scopy, patients with abnormal radiological findings, such
as hydronephrosis, a solid mass within the urinary tract,
gross hematuria originating from the upper urinary tract,
or positive urine cytology with a normal bladder mucosal
appearance were considered to be candidates. In patients
with apparent imaging findings and positive urinary
cytology, we generally proceeded with radical surgery
without diagnostic ureteroscopy.
Details of procedure
Before ureteroscopy, almost all patients underwent
cystoscopy, CT, and voided urine cytology at our out-
patient clinic. Under general (n = 86) or lumbar (n =
80) anesthesia, we initially performed cystoscopy and,
thereafter, observed the upper urinary tract using a
semi-rigid ureteroscope. Since 1998, flexible uretero-
scopy has also been available in our hospital. Although,
during the study period, several models of uretero-
scopes were used due to the introduction of new
models or simply the wear and tear of equipment, a
semi-rigid ureteroscope of Richard Wolf (size: 6.0-7.5
Fr, working channel: 4 Fr) and a flexible ureteroscope
of Olympus (size: 5.3-8.4, working channel: 3.6 Fr)
were mostly used. With the use of 3 Fr forceps, biopsy
of any suspicious region was performed, and samples
were processed in formalin fixative. Washing urine
samples were also collected. In patients with abnormal
cytological findings without apparent abnormal radio-
logical findings, random biopsy of the bladder mucosa
was also conducted.
In the present study, we examined the diagnostic out-
come at the initial ureteroscopy. Thereafter, we collected
follow-up data on patients who had been diagnosed
without UC of the UUT, and evaluated the incidence of
later cancer detection and associated risk factors.
Statistical analysis
Cox proportional hazard model addressed the associ-
ation between the clinical characteristics and later can-
cer detection. Survival probabilities were estimated using
Kaplan-Meier methods, and survival distributions were
compared with the log-rank test. All calculations were
performed using JMP version 11. P-values < 0.05 were
considered significant.
Results
Table 1 shows the patients’ characteristics. The median
age was 67.5 years (range: 22–89). Of the 166 patients,
118 (71.1 %) underwent diagnostic ureteroscopy based
on abnormal radiological findings, 76 (45.8 %) based on
abnormal cytology findings, and 78 (47.0 %) due to macro-
hematuria (there were overlaps among the groups). In the
present cohort, 55 (33.1 %) patients had a concurrent or
previous history of bladder cancer.
Figure 1 summarizes the diagnostic outcomes of initial
examinations. Of the 166 patients, UC of the UUT was
detected in 76 (45.8 %) patients. After the diagnosis, 42
patients underwent nephroureterectomy, 2 underwent
nephroureterocystectomy, 2 underwent partial ureterect-
omy, 1 patient with bilateral UC of the UUT underwent
nephrouretectomy and contralateral partial ureterect-
omy, and 5 underwent endoscopic conservative surgery.
Pathological examination after surgery revealed that 49
patients had UC of the UUT, while 3 patients did not
show evidence of carcinoma in the surgical specimens.
The remaining 24 patients underwent non-surgical
Table 1 Patients’ characteristics
n = 166
Age, years Median: 67.5
(range: 22–89)
Sex male/female
Male 107 (64.5 %)
Female 59 (35.5 %)
Side evaluated by ureteroscopy
Unilateral 143 (86.1 %)
Bilateral 23 (13.9 %)
Reason for undergoing ureteroscopy
Abnormal radiological finding only 39 (23.5 %)
Abnormal cytological finding onlya 21 (12.7 %)
Macrohematuria only 13 (7.8 %)
Multiple reasons any of the above 3 indications 83 (50 %)
Missing information 10(6 %)
Concurrent or previous history of bladder cancer
Yes 55 (33.1 %)
No 111 (66.9 %)
aAbnormal cytological finding means malignant, suspicious, or atypical cells
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treatment (BCG instillation into upper urinary tract:
n = 6, systemic chemotherapy: n = 7, palliative therapy:
n = 6, and observation: n = 5). Figure 2 summarizes the
diagnostic outcomes of the remaining 90 patients
without UC of the UUT at the first examination. Fifty
patients, in whom no apparent tumor was observed on
ureteroscopic evaluation or pathological evaluation,
and washing cytology did not lead to a definitive diagnosis
of UC, were considered to be without malignancy or uro-
logical disorder. In 22 patients, malignant diseases other
than UC of the UUT (bladder cancer: n = 16, renal cell
carcinoma: n = 2, other malignancies n = 4) were detected.
In addition, non-malignant disorder was detected in 18
patients (ureteral stricture: n = 10, benign tumor: n = 4,
urolithiasis: n = 2, others: n = 2). Regarding the compli-
cations among the 166 patients, major ureteral injury
occurred in one patient with a ureteral stone and severe
hydronephrosis, which later resulted in nephrectomy.
Minor ureteral injury occurred in 7 patients, which was
resolved by ureteral stent placement. No urosepsis
occurred after ureteroscopy.
After the first ureteroscopy, follow-up data were avail-
able in 65 patients with a median 41-month (range: 3–
170 months) follow-up duration, while 25 patients were
lost to follow-up. During the follow-up period, 11 pa-
tients underwent a second ureteroscopy, and UC of the
UUT was detected in 5 patients. An additional patient
developed metastatic urothelial carcinoma 33 months
after the first examination (case No. 6 in Table 2).
Therefore, UC of the UUT was detected in a total of 6
patients (6/65, 9.2 %) at a median of 43.5 months (range:
10–59 months) after the first ureterosopy (Fig. 2 and
Fig. 1 Summary of the first examination. UC = urothelial carcinoma. UUT = upper urinary tract
Fig. 2 Summary of the remaining 90 patients without UC of the UUT at the first examination
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Table 2). Table 3 summarizes the results of uni- and
multivariate analyses of risk factors for later cancer
detection. Episodes of gross hematuria (p = 0.0048) and
abnormal cytological findings (p = 0.0335) during the
follow-up and a male sex (p = 0.0316) were adverse risk
factors of later cancer detection. When using a multi-
variate model adjusting for episodes of gross hematuria
and abnormal cytological findings, episodes of gross
hematuria remained significant (hazard ratio: 7.84, 95 %
confidence interval: 1.32-61.7, p = 0.0239).
Discussion
In the present study, 76 (45.8 %) of the 166 patients
were diagnosed with UC of the UUT at the first examin-
ation. Although the detection rate of UC of the UUT
was lower than in previous studies [5, 6], we consider
Table 2 Summary of the 6 patients with later detection of UC of the UUT
Case No. Age, years Sex Side of first
examination
Mucosa appearance








1 55 Male L normal not performed not performed bladder cancer
2 71 Male R normal negative negative free of disorders
3 82 Male R normal atypical not performed bladder cancer
4 68 Male R irregular negative negative bladder cancer
5 70 Male L normal negative not performed free of disorders
6 85 Male L normal atypical negative free of disorders













1 L No negative ureteroscopy 57 nephroureterectomy UC,G3 > 2,pT3
2 R Yes negative ureteroscopy 10 nephroureterectomy UC,G1 > 2,pT2
3 R No negative ureteroscopy 60 nephroureterectomy UC,G3,pT3
4 R Yes suspicious ureteroscopy 28 BCG UC, G2 > G3, pTa
5 B Yes positive ureteroscopy 55 BCG for CIS of UUT -
6 L Yes suspicious CT 33 palliative therapy -
Table 3 Univariate and multivariate analysis of risk factors for later cancer detection
Factor No. of patients Univariate hazard ratio
(95 % confidence interval)
P-value Multivariate hazard ratio
(95 % confidence interval)
P-value
Age, year
continuous 65 1.07 (0.99-1.18) 0.0807
Gross hematuria after first examination
Yes 13 11.3 (2.15-82.8) 0.0048 7.84 (1.32-61.7) 0.0239
No 50 1 1
Cytology after first examination
Positive/suspicious/atypical 9 6.6 (1.18-37.0) 0.0335 4.58 (0.689-31.3) 0.112
Negative 47 1 1
Concurrent or previous history of bladder cancer
Yes 22 3.09 (0.6-22.4)
No 43 1 0.177
Smoking history
Yes 32 4.08 (0.66-78.1)
No 26 1 0.142
Sex 5-year cancer-free survival rate, %
Male 40 73
Female 25 100 0.0316
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that it is strongly influenced by the indication of diag-
nostic ureteroscopy at each institution. As aforemen-
tioned, we proceed directly to radical surgery without
ureteroscopy in patients showing apparent imaging find-
ings with a positive urinary cytology, and this would
contribute to our lower detection rate. The incidence of
urinary stones was low in our cohort, because patients
requiring stone treatment were usually referred to our
teaching hospitals.
At the initial diagnosis, UC of the UUT was not de-
tected in surgical specimens in 3 patients (5.8 %, 3/52).
The final pathology revealed dysplasia in one patient and
the remaining two patients had neither carcinoma nor
dysplasia. Of these three patients, one was diagnosed
with a pelvic tumor due to positive washing cytology.
This patient had concurrent bladder carcinoma, and
contamination by carcinoma cells from bladder cancer
would lead to a misdiagnosis. The remaining two pa-
tients were diagnosed by mucosal biopsy, which would
suggest the difficulty of pathological diagnosis using
small biopsy samples. Tsivian et al. reported a similar
rate of misdiagnosis (not UC based on final pathologic
findings), whereby it was 2.1 % (1/48) with routine
ureteroscopic assessment [5]. Interestingly, they re-
ported that the rate of misdiagnosis was 15.5 % (9/58)
before routine ureteroscopic evaluation, which sug-
gested improvement of the diagnostic accuracy due to
ureteroscopy.
After the first ureteroscopy, follow-up data were
available in 65 patients with a median of 41 months
(range: 3–170 months), and UC of the UUT was de-
tected on second ureteroscopy in 5 patients. Because
one additional patient developed metastatic urothelial
carcinoma detected by CT, UC of the UUT was de-
tected in a total of 6 patients (6/65, 9.2 %) at a median
of 43.5 months (range: 10–59 months) after the first
ureteroscopy, which was an unexpectedly high detec-
tion rate. Regarding Case 2 in Table 2, because the
interval between the first ureteroscopy and definitive
diagnosis was relatively short (10 months), we consid-
ered that UC of the UUT carcinoma might be missed
at the first examination. In the remaining 5 patients,
because UC of the UUT was diagnosed after more
than two years (range: 28–60 months), these carcin-
omas might be de novo development rather than being
missed at the first examination. Cases 1, 3, and 4 had
concurrent bladder cancer, and it is well-known that
patients with bladder cancer are at risk of upper urin-
ary tract recurrence. Picozzi et al. reported in their
meta-analysis that the incidence of upper urinary tract
recurrence after cystectomy ranged from 0.75 to 6.4 %
[7]. However, interestingly, the laterality of the carcin-
oma was the same as that observed at the first exam-
ination in all 6 cases, although we could not clarify the
precise mechanism. At present, we consider our ob-
servations to suggest that later cancer detection of UC
of the UUT was not uncommon after the first examin-
ation, but this should be verified in another cohort.
Regarding the risk factors of later cancer detection, the
univariate model identified episodes of gross hematuria
(p = 0.0048) and abnormal cytological findings (p = 0.0335)
during the follow-up and a male sex (p = 0.0316) as ad-
verse risk factors. Regarding the sex difference, previous
epidemiologic studies revealed conflicting observations
of a male [8–10] or a female [11] predominance in the
incidence of UC of the UUT. Alternatively, a difference
in accessibility to the upper urinary tract between males
and females, due to differences in the urethral length,
may influence the outcome. In the present study, the
hazard ratio of males to females could not be calculated
due to the absence of later cancer detection in the
female cohort. When adjusting for episodes of gross
hematuria and abnormal cytological findings in the multi-
variate model, episodes of gross hematuria remained sig-
nificant (hazard ratio: 7.84, 95 % confidence interval:
1.32-61.7, p = 0.0239).
This study had several limitations, including its retro-
spective design, small sample size, and variations in
ureteroscopies, as well as each surgeon’s experience and
proficiency during the study periods. In addition, we
could not follow all patients after the first examination
and did not have a uniform follow-up protocol, such as
an indication for repeat ureteroscopy. Nevertheless, we
consider that several important findings were yielded by
the present study.
Conclusion
Later cancer detection of UC of the UUT was not uncom-
mon after the first examination. Risk analysis revealed that
episodes of gross hematuria (p = 0.0048) and abnormal
cytological findings (p = 0.0335) during the follow-up and
a male sex (p = 0.0316) were adverse risk factors.
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